RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-8.89%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$3.57B
AUM Growth
+$3.57B
(-15%)
Cap. Flow
+$230K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
48.82%
Holding
78
New
14
Increased
15
Reduced
33
Closed
9
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$75.7M |
| 2 |
Merck
MRK
|
$60.7M |
| 3 |
Beam Therapeutics
BEAM
|
$60.5M |
| 4 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$56.7M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$52.7M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$116M |
| 2 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
$109M |
| 3 |
Boston Scientific
BSX
|
$73.8M |
| 4 |
Centene
CNC
|
$43.3M |
| 5 |
HCA Healthcare
HCA
|
$42.2M |
Sector Composition
| 1 | Healthcare | 97.84% |
| 2 | Industrials | 0.87% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Elevance Health
ELV
$72.4B
| – | – |
-100,800
| Closed | -$30.4M |
|
|
77
Boston Scientific
BSX
$159B
| – | – |
-1,631,200
| Closed | -$73.8M |
|
|
78
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-1,800,800
| Closed | -$116M |
|